Generation of vaccine
manufacturing stepProtocol: Phase I clinical trial protocol in patients with advanced (stage III or IV) melanoma
The DC vaccine will consist of monocyte derived DC loaded with tumor lysate generated from the excised lesion.
created over 16 years ago (2 March 2009) last modified over 13 years ago (28 September 2011)  [ RDF ]  [ RelFinder ]